Subclinical neurological involvement does not develop if Wilson's disease is treated early(123 visite) Dubbioso R, Ranucci G, Esposito M, Di Dato F, Topa A, Quarantelli M, Matarazzo M, Santoro L, Manganelli F, Iorio R
Parole chiave: Neurological Diagnostic Techniques, Outcome, Therapy, Wilson, S Disease,
Affiliazioni:
*** IBB - CNR *** Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Italy., Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Italy., Institute of Biostructure and Bioimaging, National Research Council (CNR), Naples, Italy., Department of Translational Medical Sciences, Section of Internal Medicine, University of Naples Federico II, Italy., Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Italy. Electronic address: riorio@unina.it.,
Riferimenti:
Ala, A., Walker, A.P., Ashkan, K., Dooley, J.S., Schilsky, M.L., Wilson's disease (2007) Lancet, 369, pp. 397-40
Kinnier Wilson, S.A., Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver (1912) Brain, 34, pp. 295-509
Brewer, G.J., Dick, R.D., Johnson, V.D., Brunberg, J.A., Kluin, K.J., Fink, J.K., Treatment of Wilson's disease with zinc: XV long-term follow-up studies (1998) J. Lab. Clin. Med., 132, pp. 264-278
Iorio, R., D'Ambrosi, M., Marcellini, M., Barbera, C., Maggiore, G., Zancan, L., Serum transaminases in children with Wilson's disease (2004) J. Pediatr. Gastroenterol. Nutr., 39, pp. 331-336
Dziezyc, K., Karliński, M., Litwin, T., Członkowska, A., Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients (2014) Eur. J. Neurol., 21, pp. 332-337
Schilsky, M.L., Long-term outcome for Wilson disease: 85% good (2014) Clin. Gastroenterol. Hepatol., 12, pp. 690-691
Bruha, R., Marecek, Z., Pospisilova, L., Nevsimalova, S., Vitek, L., Martasek, P., Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation (2011) Liver Int., 31, pp. 83-91
Ranucci, G., Di Dato, F., Spagnuolo, M.I., Vajro, P., Iorio, R., Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study (2014) Orphanet J. Rare Dis., 9, p. 41
Nicastro, E., Ranucci, G., Vajro, P., Vegnente, A., Iorio, R., Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease (2010) Hepatology, 52, pp. 1948-1956
Aggarwal, A., Aggarwal, N., Nagral, A., Jankharia, G., Bhatt, M., A novel Global Assessment Scale for Wilson's Disease (GAS for WD) (2009) Mov. Disord., 24, pp. 509-518
EASL clinical practice guidelines: Wilson's disease (2012) J. Hepatol., 56, pp. 671-685
Roberts, E.A., Schilsky, M.L., American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update (2008) Hepatology, 47, pp. 2089-2111
Di Lazzaro, V., Manganelli, F., Dileone, M., Notturno, F., Esposito, M., Capasso, M., The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of theipsilateral and contralateral motor cortex (2012) J. Neural Transm., 119, pp. 1499-1506
Dubbioso, R., Moretta, P., Manganelli, F., Fiorillo, C., Iodice, R., Trojano, L., Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy (2012) J. Neurol., 259, pp. 833-837
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression (1961) Arch. Gen. Psychiatry, 4, pp. 561-571
Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A., Gornbein, J., The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia (1994) Neurology, 44, pp. 2308-2314
Patton, J.H., Stanford, M.S., Barratt, E.S., Factor structure of the Barratt impulsiveness scale (1995) J. Clin. Psychol., 51, pp. 768-774
Perretti, A., Pellecchia, M.T., Lanzillo, B., Campanella, G., Santoro, L., Excitatory and inhibitory mechanisms in Wilson's disease: investigation with magnetic motor cortex stimulation (2001) J. Neurol. Sci., 192, pp. 35-40
Jhunjhunwala, K., Prashanth, D.K., Netravathi, M., Nagaraju, B.C., Pal, P.K., Alterations of cortical excitability and central motor conduction time in Wilson's disease (2013) Neurosci. Lett., 553, pp. 90-94
McGee, T.P., Houston, C.M., Brickley, S.G., Copper block of extrasynaptic GABAA receptors in the mature cerebellum and striatum (2013) J. Neurosci., 33, pp. 13431-13435
Tecchio, F., Assenza, G., Zappasodi, F., Mariani, S., Salustri, C., Squitti, R., Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin (2011) Int. J. Alzheimers Dis., 2011, p. 292593
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(198 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
126 Records (109 escludendo Abstract e Conferenze). Impact factor totale: 451.065 (398.065 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 474.192 (409.653 escludendo Abstract e Conferenze).
ibb.cnr.it